STAT
MAY 7, 2025
A federal judge has sided with the U.S. Food and Drug Administration over a decision last year to remove two Eli Lilly drugs — the Zepbound weight loss medicine and the Mounjaro diabetes treatment — from a shortages list kept by the agency. The move means that patients will no longer have access to cheaper versions from compounding pharmacies.
PharmaVoice
MAY 7, 2025
RFK Jr.’s plan to ban TV advertising may shift more marketing attention to online platforms.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 7, 2025
In January, San Francisco’s Union Square was bustling with hordes of drug developers and investors, pounding the pavement on their way from meeting to meeting. But Rohan Ganesh, an investor at the VC firm Obvious Ventures, wasn’t among them. He only agreed to hear one company’s pitch during this year’s J.P. Morgan Healthcare Conference.
Drug Patent Watch
MAY 7, 2025
"The Patent Box Tax Incentive: A Game-Changer for Pharmaceutical Innovation? As the pharmaceutical industry continues to drive groundbreaking research and development, a lesser-known tax incentive has emerged as a key catalyst for innovation. The Patent Box tax regime, introduced in the UK in 2013, has been hailed as a success in fostering a culture of R&D and entrepreneurship.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharmaceutical Technology
MAY 7, 2025
Novo Nordisk has cut its sales and profits forecasts for 2025 due to lower demand in the US for blockbuster weight loss and diabetes drugs.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
MAY 7, 2025
Various industries have welcomed news of a trade deal between the UK and India, but Britain's pharma sector isn't among them
The Pharmacist
MAY 7, 2025
New government investment for general practice premises must ensure that pharmacists working in these settings have the facilities they need to do their job properly, the Pharmacists' Defence Association (PDA) has urged. It comes as more than 1,000 GP practices in England will be given funding from the government for quick fix estate upgrades this […] The post GP premises investment must improve pharmacist workspaces, urges PDA appeared first on The Pharmacist.
PharmExec
MAY 7, 2025
Results from the Phase III MYR301 trial show that 36% of patients who achieved undetectable hepatitis delta virus levels when treated with bulevirtide maintained suppression for nearly two years.
European Pharmaceutical Review
MAY 7, 2025
The UK and India have agreed a major trade deal, however it does not provide sufficient support the UK pharmaceutical industry, according to the Association of the British Pharmaceutical Industry (ABPI). While the UK government considers the agreement to be the UKs largest and most economically significant bilateral trade deal since its EU exit in 2020, the industry body argued that it does not address key areas such as intellectual property protections for innovators within the Indian market.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
MAY 7, 2025
As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have a chance to lead aligning innovation with access drivers and gaining a competitive edge in a changing global landscape.
Pharmaceutical Technology
MAY 7, 2025
The US FDA has granted regenerative medicine advanced therapy (RMAT) designation to Opus Genetics gene therapy OPGx-LCA5
Pharma Marketing Network
MAY 7, 2025
In an era where attention spans are shorter and healthcare stakeholders are increasingly digital-first, executing pharma marketing strategies that truly deliver ROI is both a challenge and a necessity. How do pharmaceutical brands cut through the clutter, earn HCP trust, and engage patients effectively? The answer lies in combining proven fundamentals with innovative tools and omnichannel integration.
Pharmaceutical Technology
MAY 7, 2025
Sareptas stock dropped by 26% after the FDA named a vocal critic of its gene therapy programme to lead its biologics division.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharmaceutical Business Review
MAY 7, 2025
The fast-track application included top-line data from the double-blind randomised Phase II clinical trial, which showed efficacy on the modified Unified Multiple System Atrophy Rating Scale (UMSARS)I alongside preclinical data confirming that the agent is a low to moderate affinity iron chaperone. ATH434, which acts as an iron chaperone, is aimed at inhibiting the aggregation of pathological proteins associated with neurodegeneration.
PharmaTech
MAY 7, 2025
BioPharm International sat down with Noah Kopcho, field application scientist at Gyros Protein Technologies, to talk about the challenges in the production of AAV vectors.
PharmExec
MAY 7, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharma Times
MAY 7, 2025
Demonstrate your skill and prowess by entering this year's awards!
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmaceutical Technology
MAY 7, 2025
At a time when investment has been low in biotech, establishing and maintaining good relationships with investors is vital.
Med Ed 101
MAY 7, 2025
When treating herpes simplex virus (HSV) or varicella-zoster virus (VZV), two antiviral agents commonly used are acyclovir and valacyclovir. While both medications are effective, understanding their pharmacokinetic profiles, dosage forms, and clinical uses can help healthcare providers make the best choice for each patient. In this blog post, I will highlight the most important differences […] The post Acyclovir Versus Valacyclovir – What’s the Difference?
PharmExec
MAY 7, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
MAY 7, 2025
At the Swiss Biotech Day 2025, which took place on 5-6 May in Basel, a panel of experts discussed three drug approval schemes.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
pharmaphorum
MAY 7, 2025
AstraZeneca and Daiichi Sankyo's Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage breast cancer for the first time
Pharmaceutical Technology
MAY 7, 2025
The European Commission (EC) has approved AstraZeneca's Bruton's tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) combo.
Pharmacy Times
MAY 7, 2025
Intravenous immunoglobulin (IVIG) treatment for dermatologic conditions shows effectiveness but poses risks of kidney decline and thromboembolism, necessitating careful monitoring.
Pharmaceutical Technology
MAY 7, 2025
Venture philanthropy organisation Solve FSHD has announced an investment of $3m in Armatus Bio to support the development of ARM-201.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
MAY 7, 2025
An AI model is being piloted at a national scale for the first time, but will it be able to predict future health risks reliably?
Pharmacy Times
MAY 7, 2025
UPMC enhances care for patients with heart failure through integrated pharmacy and cardiology team collaboration.
PharmaTech
MAY 7, 2025
This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Expert insights. Personalized for you.
285 
Let's personalize your content